Phoenix Life Science Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 15-11-2024
- Paid Up Capital ₹ 5.00 M
as on 15-11-2024
- Company Age 15 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.20 Cr
as on 15-11-2024
- Satisfied Charges ₹ 5.20 M
as on 15-11-2024
- Revenue 13.13%
(FY 2023)
- Profit 5.48%
(FY 2023)
- Ebitda 12.43%
(FY 2023)
- Net Worth 35.86%
(FY 2023)
- Total Assets 5.05%
(FY 2023)
About Phoenix Life Science
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹2.20 Cr. The company has closed loans amounting to ₹5.20 M, as per Ministry of Corporate Affairs (MCA) records.
Sanjay Narwal and Bimla Devi serve as directors at the Company.
- CIN/LLPIN
U24233DL2009PTC195861
- Company No.
195861
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Nov 2009
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Phoenix Life Science Private Limited offer?
Phoenix Life Science Private Limited offers a wide range of products and services, including Common Disease Medicines, Anti Acne Drug, Door, Window Handles & Knockers, Cabinet Handles, Switches & Switch Boxes, Safety Switches, Animal Medicines & Health Care, Veterinary Vaccines, Antacid Drugs, Allopathic Liver Tonic.
Who are the key members and board of directors at Phoenix Life Science?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjay Narwal  | Director | 09-Nov-2009 | Current |
| Bimla Devi | Director | 19-Jan-2020 | Current |
Financial Performance of Phoenix Life Science.
Phoenix Life Science Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 13.13% increase. The company also saw a slight improvement in profitability, with a 5.48% increase in profit. The company's net worth Soared by an impressive increase of 35.86%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Phoenix Life Science?
In 2023, Phoenix Life Science had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 28 Apr 2022 | ₹0.46 M | Open |
Hdfc Bank Limited Creation Date: 31 Oct 2014 | ₹2.16 Cr | Open |
State Bank Of India Creation Date: 26 Feb 2014 | ₹3.10 M | Satisfied |
How Many Employees Work at Phoenix Life Science?
Phoenix Life Science has a workforce of 62 employees as of Mar 27, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Phoenix Life Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Phoenix Life Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
